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Abstract: Superselective arterial embolization is a common therapeutic procedure for cases 
of visceral hemorrhage. However, until now, it has not been applied in the treatment of gastro-
intestinal (GI) hemorrhage caused by acute graft-versus-host disease (GVHD) after allogeneic 
hematopoietic stem cell transplantation. We describe a case presenting with persistent GI bleed-
ing associated with acute GVHD successfully treated by superselective arterial embolization of 
the superior mesenteric artery with gelatin sponge after noneffective conventional management. 
This case will help guide hematologists to deal with a similar situation in the future.
Keywords: gastrointestinal bleeding, acute graft-versus-host disease, allo-hematopoietic stem 
cell transplantation, arterial embolization
Background
Acute graft-versus-host disease (GVHD), the immunologic attack of transplanted 
donor T lymphocytes against foreign host tissues, is a major complication of allogeneic 
hematopoietic stem cell transplantation (HSCT). The skin, liver, and gastrointestinal 
(GI) tract are the main targets of acute GVHD.1–4 GI tract involvement is less common 
compared with that of skin and liver1 but is recognized as the most severe and difficult to 
treat, especially GI hemorrhage.2 The incidence of GI hemorrhage following bone mar-
row transplants is approximately 10%,5 and its mortality can reach as high as 30%–60% 
in patients who experience acute GVHD.6 Though overt GI bleeding is uncommon, 
because of the frequent problem of severe thrombocytopenia, when it occurs, GI 
bleeding requires prolonged hospitalization and often results in mortality.
Routine therapy for GI bleeding is based on intensive supportive treatment, such 
as transfusion of blood cells, infusion of coagulation factors, and use of hemostatic 
agents,7 but their effect on controlling severe GI hemorrhage is limited. Where these 
conservative measures have failed, numerous therapeutic approaches, including endo-
scopy and surgery, have been tried with little success in patients with hematopoietic 
malignancies. Recently, a new technique named superselective arterial embolization 
(SAE) has been attempted in our hospital. SAE is a safe and minimally invasive 
method used as treatment for severe visceral bleeding and may be especially valuable 
to patients whose initial conservative therapy is ineffective, or after a failed primary 
endoscopic approach. However, to the best of our knowledge, there are no publications 
showing that SAE has been applied to treating GI bleeding caused by acute GVHD 
following HSCT. Herein, we report a case of a patient with severe GI hemorrhage 
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after allogeneic HSCT successfully treated by means of SAE 
of the superior mesenteric artery.
Case presentation
A 51-year-old Chinese female presenting with general 
weakness and pancytopenia for half a year was admitted to 
our hospital. A complete blood cell count analysis showed 
mild anemia, with a hemoglobin level of 87 g/L, white 
blood cell (WBC) count of 2.35×109/L, and platelet count of 
23×109/L. Myelodysplastic syndrome (refractory cytopenia 
with multilineage dysplasia) was diagnosed by bone marrow 
examination, and karyotyping revealed 20q-:29.2% (73/250). 
After being conditioned with fludarabine, busulfan, high-
dose cyclophosphamide, and antithymocyte globulin as a 
preparative regimen, allogeneic peripheral blood stem cell 
transplantation from her human leukocyte antigen (HLA)-
matched sibling was performed. Engraftment was apparent 
on day 16 after transplantation, with total leukocytes recover-
ing, from less than 0.5×109/L before transplantation to over 
1×109/L. Prophylaxis for GVHD consisted of cyclosporin A,   
Mycophen, and high-dose dexamethasone. Despite these 
intensive efforts, by day 30, the patient had developed watery 
diarrhea, burst oral mucosa, skin rash, and abnormal liver 
function. Her alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) of serum were 301 IU/L and 106 IU/L, 
respectively, and her serum albumin was only 28 g/L, which 
was lower than the normal value. These symptoms and labo-
ratory indexes strongly suggested the onset of acute GVHD, 
so the patient was additionally given supporting treatment, 
including magnesium isoglycyrrhizinate, omeprazole, ber-
berine, and Smecta®, to improve liver function, protect the 
stomach, and control the symptom of diarrhea.
Cytomegalovirus (CMV) infection was diagnosed 
at day 80 after transplantation, with the level more than 
5×102 Copies/mL, so the patient was treated with ganciclo-
vir. The patient started GI bleeding at day 90, accompanied 
with abdominal cramping and bloody diarrhea of total 400 
to 500 mL approximately five times per day. Multiple trans-
fusions of red blood cell (RBC) concentrates, platelet, fresh 
frozen plasma, high-dose prednisolone, broad-spectrum 
antibiotics, antiviral coverage, and even daily hemostatic 
agents were utilized. The patient received therapeutic doses 
of RBC concentrates and platelet transfusions for more than 
20 consecutive days after the symptom of bloody diarrhea 
began. However, despite all these efforts, the bloody diar-
rhea could not be stopped.
Upper and lower endoscopies were performed, which 
revealed multiple superficial mucosal lesions of the 
duodenum and active oozing of blood from the ileocecal 
junction (Figure 1), and the biopsy specimen revealed lym-
phocytic duodenitis, which was consistent with GVHD. The 
problem ahead of us was controlling the severe GI hemor-
rhage of a patient with RBC counts less than 3×109/L, hemo-
globin level less than 60 g/L, and platelet counts less than 
30×109/L, with a safe method. After careful consideration, 
we made a bold attempt to introduce the technique of SAE 
for the treatment of this patient.
The procedure was performed in an angiography room 
under fluoroscopic guidance. Using local anesthetics, a 
retrograde catheterization of the left femoral artery was 
carried out in order to perform digital angiography of the 
aortoiliac sector, by modified Seldinger’s technique. Subse-
quently, selective catheterization of the celiac artery, with 
a standard angiographic catheter (Cobra 5F), was carried 
out to localize the bleeding vessels. Then, the catheter was 
guided into the superior mesenteric artery at the initial 
segment of the pancreaticoduodenal artery, where digital 
subtraction angiography (DSA) showed obvious signs of 
contrast extravasation, which was confirmed as the bleed-
ing site (Figure 2A). A Progreat® microcatheter was guided 
into the bleeding branch, and DSA confirmed the previ-
ous finding again; then 700 to 1,000 µm gelatin sponge 
microparticles were used to occlude the bleeding branch of 
the pancreaticoduodenal artery until blood flow was ceased. 
Subsequently, a further angiography was performed to 
confirm the occlusion of the bleeding branches (Figure 2B). 
The catheter was removed after verifying that there were no 
other bleeding sites. Action of the unilateral lower limb was 
prohibited for over 12 hours after the angiography.
The patient’s GI bleeding stopped following the arterial 
embolotherapy; there was no further bleeding at the site 
of embolism and also no clinically obvious bowl necrosis. 
Two days later, a fecal occult blood test was performed, and 
the result was negative. The counts of RBCs and hemoglobin 
also increased gradually, while bloody diarrhea and related 
symptoms had ceased after treatment and had no recurrence. 
Though GVHD still existed, the GI hemorrhage had been 
fully controlled.
Discussion
GI bleeding is a significant cause of morbidity and mortal-
ity of patients suffering from acute GVHD.8 Therapy for GI 
hemorrhage is usually conservative and is accompanied by 
supportive care, and surgical intervention is rarely needed and 
generally avoided given the rebleeding risks of the newly trans-
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we decided to utilize SAE as our treatment option. To our 
knowledge, this is the first reported case of the use of SAE for 
controlling GI bleeding secondary to acute GVHD.
These days, SAE plays an increasing role in hemor-
rhage therapy, and it is an accepted approach for intractable 
hemorrhage, offering the obvious advantage of a lower rate 
of morbidity.10,11 Several studies have confirmed the role of 
SAE in controlling GI bleeding.12–23 Though endoscopy could 
also be the choice to establish hemostasis,24 this patient’s low 
platelet count (less than 30×109/L) and extensive mucosal 
hemorrhage were the contraindications for endoscopy 
treatment. Hence, in this case, endoscopy was only used to 
initially evaluate and diagnose acute GI GVHD.
The reasons for our choices were as follows: firstly, 
conventional treatment was ineffective for this patient; sec-
ondly, the SAE technique is very mature to stop bleeding, in 
our hospital, for dealing with hemorrhage – though we knew 
that potential side effects of SAE might occur, the surgeons per-
forming this procedure were all very experienced, having done 
more than 100 cases per month in our hospital; thirdly, gelatin 
sponges have been used extensively as an absorbable hemostatic 
agent with no toxic or antigenic effects on the body.
This case indicated that SAE offers an opportunity for 
both diagnostics and therapeutics in the management of 
acute GVHD complicated by GI hemorrhage. However, 
we should also be careful, throughout the embolization, to 
Figure 1 endoscopic examinations.
Notes: Gastroscopy showed multiple superficial mucosal lesions of duodenum and diffuse mucosal bleeding (A and B), and colonoscopy indicated active oozing of blood 
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prevent potential complications, such as fever, hematoma, 
buttock ischemia, vascular perforation, and infection. 
Before choosing the technique of SAE, hospital facilities 
and surgeons’ experience should also be considered. What 
is more, for a better understanding of the therapeutic and 
adverse effects of SAE in controlling GI hemorrhage after 
HSCT, a large sample of clinical trial is needed in the 
future. After this first attempt, we confidently believe that 
this case will provide a good example and help guide hema-
tologists to deal with a similar situation in the future.
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